Sign in
4

Changes in Ownership

Allogene Therapeutics, Inc. Filed Acc 0001737287-25-000004

President and CEO acquired 552,174 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Chang David D · President and CEO

Table I: Non-derivative

1 line
Date Transaction Shares Owned after D/I
2025-01-24 Grant or award : show line 1 in the form +552,174 5,363,240 D

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2025-01-24 Grant or award : show line 2 in the form Stock Option (Right to buy) +1,952,130 1,952,130 D
Loading xslF345X05/wk-form4_1738113042.xml…